Ceca Clinical Innovations Private Limited
About Ceca Clinical Innovations Private Limited
Data last updated:
Ceca Clinical Innovations Private Limited was a private limited company based in Allepey, Kerala, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 August 2009.
The company was registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74900KL2009PTC024578. Its GSTIN is 32AADCC7180R1Z8 (Kerala).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Krishna Hari and Kamalam Pillai.
Its last annual general meeting (AGM) was held on 01 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 30/377 Perumpillil C.M.C – 26 Shertallay, Allepey, Kerala, India – 688524.
As per the financials filed for FY 2018, the company reported a revenue of ₹24.59 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net profit of ₹20,166 (net margin 0.8%) and EBITDA of ₹80,769 (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years.
Company details
Contact details
Ceca Clinical Innovations Private Limited's registered office is in Allepey, Kerala. Its e-mail address is in the company report.
- Email
- Registered Address30/377 Perumpillil C.M.C – 26 Shertallay, Allepey, Kerala, India – 688524
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ceca Clinical Innovations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ceca Clinical Innovations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ceca Clinical Innovations Private Limited, buy the company report.
Financials of Ceca Clinical Innovations Private Limited
FY 2018 filings availableCeca Clinical Innovations Private Limited reported revenue of ₹24.59 Lakh (down 72% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 31% over three years, including a 72% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹80,769 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹20,166 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.3% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ceca Clinical Innovations Private Limited, buy the company report.
Board of directors of Ceca Clinical Innovations Private Limited
Ceca Clinical Innovations has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Hari | Director | 01 Jul 2010 | 16 Years 4 Months | As last reported |
| Kamalam Pillai | Director | 01 Dec 2018 | 7 Years 11 Months | As last reported |
Auditor
Ceca Clinical Innovations Private Limited is audited by DEV & SANKAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEV & SANKAR | FY 2017 | 000720S |
Shareholding
The shareholding of Ceca Clinical Innovations Private Limited is on record for FY 2017, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ceca Clinical Innovations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ceca Clinical Innovations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ceca Clinical Innovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ceca Clinical Innovations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCC7180R1Z8 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ceca Clinical Innovations Private Limited, buy the company report.
Recent activity
Ceca Clinical Innovations Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Achuthan Valiyaparambil Sathyanandan ceased to be Director on 30 Mar 2019.
Frequently asked questions
Ceca Clinical Innovations has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ceca Clinical Innovations was a private limited company based in Allepey, Kerala, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 August 2009 and is registered under CIN U74900KL2009PTC024578. The company has been struck off by the Registrar of Companies and is no longer operational.
Ceca Clinical Innovations had 2 directors:
- Krishna Hari - Director
- Kamalam Pillai - Director
The CIN (Corporate Identification Number) of Ceca Clinical Innovations is U74900KL2009PTC024578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ceca Clinical Innovations is at 30377 Perumpillil C.M.C – 26 Shertallay, Allepey, Kerala, India – 688524.
Ceca Clinical Innovations was incorporated on 10 August 2009. It is registered with the Registrar of Companies, Ernakulam.
The latest financial statements of Ceca Clinical Innovations on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 01 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Ceca Clinical Innovations is 32AADCC7180R1Z8, registered in Kerala.
Ceca Clinical Innovations operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Achuthan Valiyaparambil Sathyanandan ceased to be Director on 30 Mar 2019. Joseph Philip ceased to be Director on 30 Mar 2019. Prasanth Pushpangadan ceased to be Director on 30 Mar 2019. Ceca Clinical Innovations has 8 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
